GHC — Garofalo Health Care SpA Share Price
- €459.14m
- €667.25m
- €462.18m
- 83
- 34
- 71
- 71
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 16.94 | ||
PEG Ratio (f) | 1.41 | ||
EPS Growth (f) | 13.6% | ||
Dividend Yield (f) | 1.8% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.42 | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | 34.26 | ||
Price to Sales | 0.99 | ||
EV to EBITDA | 9.61 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 6.26% | ||
Return on Equity | 6.99% | ||
Operating Margin | 9.55% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | €m | 206.78 | 277.87 | 314.76 | 360.98 | 462.18 | 480.8 | 489.4 | 18.92% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -12.78 | +75.26 | +17.82 | -10.97 | -0.7 | +17.39 | +6.67 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Garofalo Health Care SpA is an Italy-based healthcare group. The Group manages facilities across northern and central Italy, both private and accredited, providing a wide range of services and specializations covering all sectors of the health and social care sectors, among others, medicine, surgery, cardiology, rehabilitation, extended and intensive care units, psychiatric and diagnostic centers. Additionally, the Company is active in the research field in collaboration with Italian and foreign research institutions and universities.
Directors
- Alessandro Rinaldi NEC
- Maria Garofalo CEO
- Claudia Garofalo EDR
- Giuseppe Giannasio EDR
- Umberto Suriani EDR
- Nicola Colavito NED (43)
- Patrizia Crudetti NED
- Alessandra Rinaldi Grofalo NED
- Grazia Bonante NID (54)
- Franca Brusco NID (50)
- Federico Luzz NID (53)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- January 1st, 1970
- Public Since
- November 9th, 2018
- No. of Employees
- 2,708
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Borsa Italiana
- Shares in Issue
- 88,465,800

- Address
- Piazzale Belle Arti 6, ROMA, 00196
- Web
- https://www.garofalohealthcare.com/
- Phone
- Contact
- Mimmo Nesi
- Auditors
- EY S.p.A
Upcoming Events for GHC
Similar to GHC
EuKedos SpA
Borsa Italiana
Health Italia SpA
Borsa Italiana
FAQ
As of Today at 20:45 UTC, shares in Garofalo Health Care SpA are trading at €5.19. This share price information is delayed by 15 minutes.
Shares in Garofalo Health Care SpA last closed at €5.19 and the price had moved by +9.96% over the past 365 days. In terms of relative price strength the Garofalo Health Care SpA share price has outperformed the FTSE Global All Cap Index by +7.21% over the past year.
The overall consensus recommendation for Garofalo Health Care SpA is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Garofalo Health Care SpA dividend yield is 1.66% based on the trailing twelve month period.
Last year, Garofalo Health Care SpA paid a total dividend of €0.09, and it currently has a trailing dividend yield of 1.66%.Looking ahead, shares in Garofalo Health Care SpA are due to go ex-dividend on 2025-05-19 and the next dividend pay date is 2025-05-21.
Garofalo Health Care SpA are due to go ex-dividend on 2025-05-19 and the next dividend pay date is 2025-05-21. The historic dividend yield on Garofalo Health Care SpA shares is currently 1.66%.
To buy shares in Garofalo Health Care SpA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €5.19, shares in Garofalo Health Care SpA had a market capitalisation of €459.14m.
Here are the trading details for Garofalo Health Care SpA:
- Country of listing: Italy
- Exchange: MIL
- Ticker Symbol: GHC
Based on an overall assessment of its quality, value and momentum Garofalo Health Care SpA is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Garofalo Health Care SpA is €6.50. That is 25.24% above the last closing price of €5.19.
Analysts covering Garofalo Health Care SpA currently have a consensus Earnings Per Share (EPS) forecast of €0.30 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Garofalo Health Care SpA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -10.01%.
As of the last closing price of €5.19, shares in Garofalo Health Care SpA were trading -2.08% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Garofalo Health Care SpA PE ratio based on its reported earnings over the past 12 months is 16.94. The shares last closed at €5.19.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Garofalo Health Care SpA's management team is headed by:
- Alessandro Rinaldi - NEC
- Maria Garofalo - CEO
- Claudia Garofalo - EDR
- Giuseppe Giannasio - EDR
- Umberto Suriani - EDR
- Nicola Colavito - NED
- Patrizia Crudetti - NED
- Alessandra Rinaldi Grofalo - NED
- Grazia Bonante - NID
- Franca Brusco - NID
- Federico Luzz - NID